Showing results (1871-1880 of 1,995) with videos related to
Sort By:
Pageof 200
Cancers|January 21, 2023
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic FeaturesZhenya Tang, Wei Wang, Su Yang, et al.Annals of the New York Academy of Sciences|December 17, 2008
Mitochondria-targeted antioxidants in the treatment of diseaseRobin A J Smith, Victoria J Adlam, Frances H Blaikie, et al.Haematologica|July 6, 2014
The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemiaHaiqing Ma, Saradhi Mallampati, Yue Lu, et al.Hepatology (Baltimore, Md.)|February 24, 2006
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activityGary A Levy, Gord Adamson, M James Phillips, et al.Redox Biology|September 1, 2020
Targeting succinate dehydrogenase with malonate ester prodrugs decreases renal ischemia reperfusion injuryTimothy E Beach, Hiran A Prag, Laura Pala, et al.Nature Aging|October 26, 2023
TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cellsTingting Hong, Jia Li, Lei Guo, et al.Applied Optics|November 23, 2006
Optics and mechanisms for the Extreme-Ultraviolet Imaging Spectrometer on the Solar-B satelliteClarence M Korendyke, Charles M Brown, Roger J Thomas, et al.American Journal of Physiology. Heart and Circulatory Physiology|May 6, 2025
Loss of RET-ROS at complex I induces diastolic dysfunction in mice that is reversed by aerobic exerciseAna Vujic, Amy Koo, Guillaume Bidault, et al.Hepatology (Baltimore, Md.)|December 17, 2008
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitisItay Shalev, Kit Man Wong, Katharina Foerster, et al.Journal of Hepatology|October 27, 2025
Utilization of liver grafts obtained from donation after medical assistance in dying: A Canadian multicenter experienceAlessandro Parente, Kevin Verhoeff, Samrat Ray, et al.Pageof 200